Skip to main content
ConductScienceScienceDex

Wanda Phipatanakul

NIH Rank #2548
Unclaimed recordClaim profile
  • Program Leader
  • R01 Holder
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 2099802Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

NIH Funding · FY2025

Linked Award Amount
$3.5M
Full award amounts, FY2025
Award Records
4
Records listing this PI
Award-Linked Rank
#2,548
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Wanda Phipatanakul. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Wanda Phipatanakul as a PI. Multi-PI records show the full award amount for context.

  • 5U01AI179563-02U01
    Controlling and Preventing Asthma Progression and Severity in Kids with Omalizumab Extension (PARK-EXT)
    Boston Children's Hospital
    $2.3M
    award amount
  • 1R01HL179094-01R01
    Radon Asthma Intervention Trial (ROME)
    Boston Children's Hospital
    $784.3K
    award amount
  • 5U01AI152033-06U01
    Genetic and microbial modifiers of Atopic Dermatitis (AD): Mechanisms of increased AD severity in patients with the R576 polymorphism in IL-4Ra and impact of S aureus skin decolonization on AD
    Boston Children's Hospital
    $510.2K
    award amount
  • 5U01AI160087-05U01
    Novel NOTCH4 Pathway of Asthma Severity in Urban School Children: Clinical Research Center, Boston Children’s Hospital
    Boston Children's Hospital
    $1
    award amount

Award organization

Organizations that administered FY2025 awards listing Wanda Phipatanakul as a PI.

FY2025 award administered by Boston Children's Hospital (MA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Boston Children's Hospital
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #2244
  6. 2024
    Entered Top 25% Nationally
    Ranked #2244
  7. 2025
    $5M Cumulative Funding
  8. 2025
    R01 Grant Holder
  9. 2025
    Program/Center Grant Leader
  10. 2026
    $10M Cumulative Funding
  11. 2026
    Entered Top 10% Nationally
    Ranked #1096

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Wanda Phipatanakul.

Raif Salim Geha
Boston Children's Hospital
3
shared awards
Talal Amine Chatila
Boston Children's Hospital
3
shared awards
Petros Koutrakis
Boston Children's Hospital
1
shared award

Explore further

Find collaborators for Wanda Phipatanakul

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →